ClinicalTrials.govpublic full text
Lisdexamfetamine Dimesylate in Residual Symptoms and Cognitive Impairment in Major Depressive Disorder.
major depressive disorder, cognitive impairment, partial response, residual symptoms, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 909073
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.